Chinese herbal medicine for patients with vascular cognitive impairment no dementia: Protocol for a systematic review

BMJ Open

Volumn 6, Issue 3, 2016, Pages

  Feng, Mei ^a,b,c   Lu, Jingmin ^c   May, Brian H ^d   Liu, Shaonan ^a,b,c   Guo, Xinfeng ^a,b,c   Zhang, Anthony Lin ^d   Xue, Charlie Changli ^b,c,d   Lu, Chuanjian ^b,c,d  

^a GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^b Guangdong Provincial Academy of Chinese Medical Sciences   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d RMIT UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ARTICLE; CHINESE MEDICINE; COCHRANE LIBRARY; COGNITION; COGNITIVE DEFECT; COMPUTER PROGRAM; DAILY LIFE ACTIVITY; DATA BASE; DEMENTIA; DRUG SAFETY; EMBASE; HERBAL MEDICINE; HUMAN; HYPERTENSION; MASSAGE; MEDLINE; META ANALYSIS (TOPIC); MOXIBUSTION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENTIFIC LITERATURE; SCREENING; SYSTEMATIC REVIEW; WANFANG DATABASE; COGNITIVE DYSFUNCTION; LITERATURE; METHODOLOGY; PSYCHOLOGICAL RATING SCALE; PUBLISHING;

HERBACEOUS AGENT;

ACTIVITIES OF DAILY LIVING; COGNITION; COGNITIVE DYSFUNCTION; DEMENTIA; DRUGS, CHINESE HERBAL; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PUBLICATION BIAS; RESEARCH DESIGN; REVIEW LITERATURE AS TOPIC;

EID: 84962299910     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-010295     Document Type: Article

References (29)

1. Ritter A, Pillai JA. Treatment of vascular cognitive impairment. Curr Treat Options Neurol 2015;17:367.
2. Levine DA, Langa KM. Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics 2011;8:361-73.
3. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003;2:89-98.
4. Black SE. Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management. J R Coll Physicians Edinb 2011;41:49-56.
5. Stephan BC, Matthews FE, Khaw KT, et al. Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND). Alzheimers Res Ther 2009;1:4.
6. Serrano S, Domingo J, Rodríguez-Garcia E, et al. Frequency of cognitive impairment without dementia in patients with stroke: a two-year follow-up study. Stroke 2007;38:105-10.
7. Wentzel C, Rockwood K, MacKnight C, et al. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001;57:714-16.
8. Qu YJ, Zhuo L, Li N, et al. Prevalence of post-stroke cognitive impairment in China: a community-based, cross-sectional study. PLoS ONE 2015;10:e0122864.
9. Jiang B, Ding C, Yao G, et al. Polysomnographic abnormalities in patients with vascular cognitive impairment-no dementia. Sleep Med 2013;14:1071-5.
10. Xu X, Guo L, Tian G. Diabetes cognitive impairments and the effect of traditional Chinese herbs. Evid Based Complement Alternat Med 2013;2013:649396.
11. Qin X, Liu Y, Wu Y, et al. A meta-analysis of Chinese herbal medicines for vascular dementia. Neural Regen Res 2013;8:1685-92.
12. Shuang XP, Tan ZH, Chen Q, et al. Efficacy and safety of TCM therapy for VCIND: a meta-analysis. Chin Arch Tradit Chin Med 2015;33:387-91.
13. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-41.
14. Wang LP, Zhang XY, Liu N, et al. Comparison of integrated traditional Chinese and western medicine therapy on vascular cognitive impairment with no dementia. Genet Mol Res 2015;14:4896-902.
15. Ingles JL, Wentzel C, Fisk JD, et al. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 2002;33:1999-2002.
16. Wentzel C, Darvesh S, MacKnight C, et al. Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic. Neuroepidemiology 2000;19:186-93.
17. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-75.
18. Experts consensus group of Chinese prevention and treatment of cognitive dysfunction. Experts' common understanding of Chinese prevention and treatment of cognitive dysfunction. Chin J Intern Med 2006;45:171-3.
19. Experts consensus group of Vascular cognitive impairment. Experts' common understanding of vascular cognitive impairment. Chin J Intern Med 2007;46:1052-5.
20. Jia JP. Attention to early diagnosis and intervention of vascular cognitive impairment. Chin J Neurol 2005;38:4-6.
21. Wu T, Li Y, Bian Z, et al. Randomized trials published in some Chinese journals: how many are randomized?. Trials 2009;10:46.
22. Zhao LQ, Rao KH, Liu HS. Experience of Wendan decoction treating for vascular cognitive impairment, no dementia. Guangming J Chin Med 2014;29:2176-7.
23. May BH, Lu C, Lu Y, et al. Chinese herbs for memory disorders: a review and systematic analysis of classical herbal literature. J Acupunct Meridian Stud 2013;6:2-11.
24. Ye S, Gu Y, Xu Y, et al. Bushen Huoxue decoction improves cognitive decline in rats with cerebral hypoperfusion. Mol Med Rep 2014;10:1635-41.
25. Liu JH, Chen J, Tan ZH, et al. Effects of dioscorea modified pill on cognitive impairment of patients with VCIND: an preliminary study of proton magnetic resonance spectroscopy. Zhonghua Yi Xue Za Zhi 2014;94:3075-8.
26. Solfrizzi V, Panza F. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract. J Alzheimers Dis 2015;43:605-11.
27. Hao Z, Liu M, Liu Z, et al. Huperzine A for vascular dementia. Cochrane Database Syst Rev 2009; (15): CD007365.
28. Xing SH, Zhu CX, Zhang R, et al. Huperzine A in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis. Evid Based Complement Alternat Med 2014;2014:363985.
29. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015;349:g7647.